Enhanc3D Genomics: Hazel Jones
Hazel Jones has been appointed as chief operating officer of UK spatial genomics company Enhanc3D. Previously, she held various roles at AstraZeneca, including executive product director of clinical data and head of business planning and operations in oncology R&D. She was also previously head of combination therapies at Cancer Research UK. Jones holds a BSc in pharmacology and a PhD in biochemistry from the University of Leeds.